Please assess the completion status of the following clinical trial:

Trial Title: Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female neonate or infant up to 1 year of age with Fitzpatrick Skin Type I-VI~* Clinical evidence of diaper dermatitis and a positive KOH result for pseudohyphae and/or budding yeast at baseline visit~* Overall Diaper Dermatitis Severity Index score at baseline visit of 4-8 (must include an overall clinical grade of at least 2 for erythema)~* Wear commercially available diapers day and night for at least 7 days prior to enrollment and during the course of the 2 year study~* Caretaker must complete informed consent process~Exclusion Criteria:~* Known sensitivity to any component of the formulation~* No other skin conditions that may confound the evaluation of the drug efficacy or tolerability~* Known sensitivity to skin care toiletry products or diapers~* History of HIV positive~* Chronic illnesses that require systemic medication that may confound the evaluation of study drug efficacy or tolerability (antibiotic therapy is not included)~* Treatment with a prescription product for diaper dermatitis or other skin condition 7 days prior to enrollment

- Gender: ALL
- Minimum Age: None
- Maximum Age: 15 Months
- Healthy Volunteers: f

Study Arms:
- Miconazole Nitrate (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).